These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 17016059)

  • 1. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study.
    Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z
    Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
    Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M
    J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.
    Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
    Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z
    J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin treatment of patients with aspirin intolerance, asthma, and nasal polyps.
    Feldweg AM; Horan RF
    Allergy Asthma Proc; 2001; 22(6):377-82. PubMed ID: 11775396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs.
    Quaratino D; Romano A; Di Fonso M; Papa G; Perrone MR; D'Ambrosio FP; Venuti A
    Ann Allergy Asthma Immunol; 2000 Jun; 84(6):613-7. PubMed ID: 10875490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Domingo MV; Marchuet MJ; Culla MT; Joanpere RS; Guadaño EM
    J Investig Allergol Clin Immunol; 2006; 16(6):364-6. PubMed ID: 17153884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study.
    Meek IL; Vonkeman HE; Kasemier J; Movig KL; van de Laar MA
    Eur J Clin Pharmacol; 2013 Mar; 69(3):365-71. PubMed ID: 22890587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ
    Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors.
    Bavbek S; Dursun B; Dursun E; Korkmaz H; Sertkaya Karasoy D
    Am J Rhinol Allergy; 2011; 25(6):411-5. PubMed ID: 22185746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance.
    Celik G; Paşaoğlu G; Bavbek S; Abadoğlu O; Dursun B; Mungan D; Misirligil Z
    J Asthma; 2005 Mar; 42(2):127-31. PubMed ID: 15871445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative safety of meloxicam in NSAID-intolerant patients.
    Kosnik M; Music E; Matjaz F; Suskovic S
    Allergy; 1998 Dec; 53(12):1231-3. PubMed ID: 9930610
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs].
    Vázquez-Cortés S; Vázquez-Fuertes L; Rodríguez-Alvarez M; Reig Rincón de Arellano I; Martínez-Cócera C
    An Med Interna; 2008 Apr; 25(4):163-7. PubMed ID: 18604331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of celecoxib in patients with aspirin-sensitive asthma.
    Woessner KM; Simon RA; Stevenson DD
    Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Clin Exp Allergy; 2002 Oct; 32(10):1491-6. PubMed ID: 12372130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meloxicam--the balance of efficacy and safety].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.